Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication-Reference-Cited by-同舟云学术

Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication

Published:2015-10-21 Issue:11 Volume:10 Page:1033-1043
ISSN:1559-2294
Container-title:Epigenetics
language:en
Short-container-title:Epigenetics

Author:

Pires-Luís Ana Sílvia,Vieira-Coimbra Márcia,Vieira Filipa Quintela,Costa-Pinheiro Pedro,Silva-Santos Rui,Dias Paula C,Antunes Luís,Lobo Francisco,Oliveira Jorge,Gonçalves Céline S,Costa Bruno M,Henrique Rui,Jerónimo Carmen

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.1080/15592294.2015.1103578

Reference51 articles.

1. Cancer statistics, 2014

2. An overview of renal cell cancer: Pathology and genetics

3. Selected Common Diagnostic Problems in Urologic Pathology: Perspectives From a Large Consult Service in Genitourinary Pathology

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The methyltransferase SETD3 regulates mRNA alternative splicing through interacting with hnRNPK;Cell Insight;2024-08

2. Alterations of histone modifications in cancer;Epigenetics in Human Disease;2024

3. Pharmacological inhibition of SMYD2 protects against cisplatin-induced renal fibrosis and inflammation;Journal of Pharmacological Sciences;2023-09

4. Relationship between histone demethylase LSD family and development and prognosis of gastric cancer;Frontiers in Immunology;2023-05-03

5. SMYD2 Expression: Its Relationship to Cytogenetic and Prognosis in a Newly Diagnosed Childhood B-Acute Lymphoblastic Leukemia;Clinical Laboratory;2023